0 Comentários
0 Compartilhamentos
1K Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Asia-Pacific Circulating Tumor Cells (CTC) Liquid Biopsy Market The Asia-Pacific Circulating Tumor Cells (CTC) liquid biopsy market size was valued at USD 139.25 million in 2025and is expected to reach USD 1035.190 billion by 2033, at a CAGR of 28.4% during the forecast period The market...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Circulating Tumor Cells (CTC) Liquid Biopsy Market - Industry Trends and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Circulating Tumor Cells (CTC) Liquid Biopsy Market Data Bridge Market Research analyses that the circulating tumor cells (CTC) liquid biopsy market which was USD 1,173.84 million in 2022, is expected to reach USD 4,170.06 million by 2030, growing at a CAGR of 17.17% during the forecast period of 2023 to 2030....0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market As per Data Bridge Market Research Analysis the Europe Circulating Tumor Cells (CTC) liquid biopsy market size was valued at USD 838.01 million in 2025and is expected to reach USD 4,775.49 million by 2033, at a CAGR of...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
In Vitro Diagnostic Liquid Biopsy Testing Market – Treatment Monitoring and Personalized MedicineMarket Overview The in vitro diagnostic liquid biopsy testing market is expanding in treatment monitoring applications, enabling real-time assessment of therapeutic response and detection of emerging resistance mutations. Liquid biopsy provides a dynamic view of tumor evolution, supporting personalized treatment adjustments. The market is projected to grow as precision medicine approaches...0 Comentários 0 Compartilhamentos 144 Visualizações 0 Anterior
-
Liquid Biopsy and Early Detection: The Holy Grail of the AI in Cancer Diagnostic MarketFor decades, diagnosing cancer definitively required a highly invasive, physical tissue biopsy. This process is inherently traumatic, expensive, and often impossible if the tumor is located deep within an organ like the lung or pancreas. Today, the global oncology sector is aggressively pursuing the "holy grail" of medicine: detecting cancer from a simple blood draw. To overcome the monumental...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Liquid Biopsy Market Analysis: Innovation, Precision Diagnostics, and Growth Opportunities Through 2033The global Liquid Biopsy Market is witnessing remarkable growth, driven by the increasing demand for non-invasive cancer diagnostics, advancements in precision medicine, and the rising prevalence of cancer worldwide. Valued at USD 15.9 billion in 2025, the market is projected to reach USD 61.1 billion by 2033, expanding at a CAGR of 19.1% during the forecast...0 Comentários 0 Compartilhamentos 813 Visualizações 0 Anterior
-
Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Middle East and Africa Circulating Tumor Cells (CTC) Liquid Biopsy Market The Middle East and Africa Circulating Tumor Cells (CTC) liquid biopsy market size was valued at USD 45.44 million in 2025and is expected to reach USD 156.31 million by 2033, at a CAGR of 16.70% during the forecast...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
U.S. Oncology Based Molecular Diagnostics Market Trends: Why Liquid Biopsy Is Gaining AttentionAccording to a new report by Polaris Market Research, the U.S. oncology based molecular diagnostics market was valued at USD 1.34 billion in 2024 and is projected to reach USD 2.29 billion by 2034, expanding at a CAGR of 5.5% over the forecast period. Growth is underpinned by rising cancer incidence, expanding adoption of personalized medicine, and accelerating use of next-generation...0 Comentários 0 Compartilhamentos 359 Visualizações 0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
